文献速递关节外科

肾移植受者与透析依赖终末期肾病患者初次全髋关节置换术的国家匹配分析

Comparing Primary Total Hip Arthroplasty in Renal Transplant Recipients to Patients on Dialysis for End-Stage Renal Disease: A Nationally Matched Analysis.
PubMed 文献 · J Bone Joint Surg Am · 2021-07-27

本研究利用PearlDiver数据库,对2010至2019年间接受初次全髋关节置换术的肾移植受者(N=1,401)与透析依赖终末期肾病患者(N=1,463)进行1:1频率匹配,各582例。结果显示透析患者住院时间更长(6.3天 vs 4.6天,p<0.01),90天再入院(OR=1.59)、2年机械并发症(OR=2.13)和翻修(OR=2.14)风险更高,1年假体周围感染风险也更高(OR=1.91),1年费用高14%(p=0.11)。结论提示关节外科医生可考虑在合适患者中延迟全髋关节置换术至肾移植后。

要点

  • 透析患者全髋关节置换术后住院时间、再入院、机械并发症和翻修风险均高于肾移植受者。
  • 透析患者1年假体周围感染风险显著增加(OR=1.91),1年费用高14%但差异未达统计学显著。
  • 对合适患者可考虑延迟全髋关节置换术至肾移植后,以减少术后并发症和费用。

核心结论

  • 与肾移植受者相比,透析依赖终末期肾病患者全髋关节置换术后再入院、并发症和费用更高。
  • 透析患者住院时间更长、90天再入院更多、2年机械并发症和翻修更多,且1年假体周围感染风险更高。
  • 结果提示关节外科医生可考虑在合适患者中延迟全髋关节置换术至肾移植后。

研究设计与样本

  • 回顾性队列研究,利用PearlDiver国家数据库识别2010至2019年接受初次全髋关节置换术的患者。
  • 肾移植受者N=1,401,透析依赖终末期肾病患者N=1,463,按9项患者特征进行1:1频率匹配,每组582例。
  • 比较住院时间、2年内再入院和并发症率、1年内总费用,采用卡方检验和多变量逻辑回归计算OR和95%CI。

主要发现

  • 透析患者平均住院时间6.3天,肾移植受者4.6天(p<0.01)。
  • 调整年龄、吸烟和糖尿病后,透析患者90天再入院风险更高(OR=1.59;95%CI 1.11-2.29,p<0.01)。
  • 透析患者2年机械并发症风险更高(OR=2.13;95%CI 1.08-4.45,p=0.03),翻修风险更高(OR=2.14;95%CI 1.14-4.01,p=0.01)。
  • 透析患者1年假体周围感染风险更高(OR=1.91;95%CI 1.02-3.71,p=0.04)。
  • 透析患者1年费用高14%(p=0.11)。

临床怎么用

  • 对于适合的终末期肾病患者,可考虑延迟全髋关节置换术至肾移植后,以降低术后并发症和费用。
  • 透析依赖患者行全髋关节置换术时,应警惕再入院、机械并发症、翻修和假体周围感染风险升高。

局限性

  • 证据等级为预后Level III。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Renal transplants are the most commonly performed solid-organ transplants worldwide. It is unclear whether a kidney transplant is associated with reduced postoperative complications in comparison with patients on dialysis for end-stage renal disease (ESRD). The purpose of this study was to utilize a national database to compare readmissions, complications, and costs associated with primary total hip arthroplasty (THA) between matched renal transplant recipients (RTRs) and patients on dialysis for ESRD. METHODS: Patients with a renal transplant (N = 1,401) and those on dialysis for ESRD (without a transplant) (N = 1,463) prior to being treated with a THA from 2010 to 2019 were identified within the PearlDiver database. RTRs and patients on renal dialysis were frequency-matched 1:1 on the basis of 9 patient characteristics, resulting in 582 patients in each group. Length of hospital stay, readmissions, complication rates up to 2 years, and total costs up to 1 year were compared between the groups using chi-square and multivariable logistic regression analyses to calculate odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: Patients on renal dialysis had an increased mean length of stay (6.3 days) compared with RTRs (4.6 days, p < 0.01). After adjusting for age, tobacco use, and diabetes, patients on renal dialysis were more likely to be readmitted by 90 days (OR = 1.59; CI = 1.11 to 2.29, p < 0.01) and have mechanical complications (OR = 2.13; CI = 1.08 to 4.45, p = 0.03) and revisions (OR = 2.14; CI = 1.14 to 4.01, p = 0.01) by 2 years. Patients on renal dialysis were also more likely to have periprosthetic joint infections at 1 year (OR = 1.91; CI = 1.02 to 3.71, p = 0.04). Patients on dialysis incurred 14% higher costs at 1 year (p = 0.11). CONCLUSIONS: Patients on renal dialysis had more readmissions, complications, and costs after THA when compared with RTRs. Specifically, patients on renal dialysis were more likely to have longer index lengths of stay, more readmissions by 90 days, and more mechanical complications and revision surgery by 2 years. Patients on dialysis also incurred higher costs and had greater odds of PJI. These results suggest that joint surgeons may consider delaying THA in suitable patients until after renal transplantation to reduce postoperative complications and costs. LEVEL OF EVIDENCE: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Douglas SJ, Pervaiz SS, Sax OC, et al. Comparing Primary Total Hip Arthroplasty in Renal Transplant Recipients to Patients on Dialysis for End-Stage Renal Disease: A Nationally Matched Analysis. J Bone Joint Surg Am. 2021. PMID: 34314395. doi:10.2106/JBJS.20.01983

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。